News Conference News ESC 2024 New ESC Guidelines Merge PAD, Aortic Diseases Into Single Document Caitlin E. Cox September 10, 2024
News Conference News SCAI 2024 No Sex-Specific Differences in PAD Therapy Outcomes: REVIVE Analysis L.A. McKeown May 10, 2024
News Conference News VIVA 2021 EMINENT: Better Patency With DES Over BMS for Fem-Pop Lesions L.A. McKeown October 12, 2021
News Conference News LINC 2020 Common-Femoral Lesions: LINC 2020 Experts Hash Out the Best PAD Treatment L.A. McKeown January 31, 2020
News Conference News ISET 2020 FDA’s First Take on New Paclitaxel Concerns in CLI Caitlin E. Cox January 24, 2020
News Conference News VIVA 2019 Calcium Conundrum: New Scores, Research Aim to Boost Outcomes in PAD Interventions L.A. McKeown November 13, 2019
News Conference News TCT 2019 LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD L.A. McKeown September 28, 2019
News Conference News SCAI 2019 Early Bird Bleed Monitoring System Shows Promise in Endovascular Procedures Yael L. Maxwell May 31, 2019
News Conference News CRT 2019 Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy L.A. McKeown March 06, 2019
News Conference News ISET 2019 PVI in Symptomatic Lower-Extremity PAD Offers Multiple Benefits, Even 2.5 Years Later Caitlin E. Cox February 07, 2019
News Conference News VIVA 2018 No Gender Difference in Patency Rates 1 Year After DCB for PAD: ILLUMENATE Substudy L.A. McKeown November 13, 2018
News Conference News VIVA 2018 Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention L.A. McKeown November 09, 2018
News Conference News ISET 2018 Noninvasive Testing of CLI: Many Ways to Draw Up a ‘Roadmap’ Caitlin E. Cox February 05, 2018
News Conference News ISET 2017 Underappreciated by Clinicians, Critical Limb Ischemia Has Dire Fallout for Patients Caitlin E. Cox February 07, 2017